Immunoglobulin lambda joining 1 (IGLJ1)

Immunoglobulin lambda joining 1 (IGLJ1) is a gene segment that encodes the joining (J) region of the variable domain of immunoglobulin lambda light chains, which are components of antibodies. During B cell development, this gene segment recombines with variable (V) and constant (C) regions to generate diverse antibodies capable of recognizing a wide range of antigens. IGLJ1's main role is to participate in creating the antigen-binding site diversity necessary for effective humoral immunity; it is not itself a drug target, enzyme, receptor, or signaling molecule but rather a genomic building block of immunoglobulin (antibody) molecules. IGLJ1 is located within the immunoglobulin lambda locus on chromosome 22. It is not considered a therapeutic target, as its function is structural/genetic, contributing to the diversity of antibodies rather than participating in direct signaling or being a receptor itself. Its biological significance lies in enabling the adaptive immune system to produce a vast array of antibodies through V(D)J recombination. There are no known drugs that selectively interact with IGLJ1, as it is not a protein target in mature B cells but rather a genomic sequence involved in gene rearrangement. There are no established safety concerns, biomarkers, or direct therapeutic mechanisms associated with this gene segment.

Other names

Immunoglobulin lambda joining region 1Lambda J1